Four’s Company? WHO Not Yet Recommending Quadrivalent Flu Vaccines
Executive Summary
While FDA has approved MedImmune’s quadrivalent version of its seasonal influenza vaccine FluMist and GlaxoSmithKline has submitted an application for approval for one, the World Health Organization is not yet ready to recommend replacing the standard trivalent vaccines.